Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113072456A details a novel copper-catalyzed asymmetric difluoromethylation for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN103087028A details a robust Grignard-Suzuki route for Nebivolol intermediates, offering cost reduction and scalable chiral chroman manufacturing for global supply chains.
Patent CN105755095A enables high-yield enzymatic deracemization. Delivers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Patent CN112430228B details a novel Rh-catalyzed route for chiral 2,3-dihydrobenzo[b]thiophene 1,1-dioxide, offering superior stereoselectivity and scalable manufacturing for API intermediates.
Novel enzymatic synthesis method for high-purity chiral cis-cyclohexanediamine. Scalable process reduces impurities and ensures supply chain reliability for anticoagulant manufacturing.
Novel synthesis route for esomeprazole intermediates via patent CN104098515B. Offers high yield, purity, and scalable production for global supply chains.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Novel patent CN105622464A enables safer chiral hydrazine production with improved purity and supply chain reliability for global pharmaceutical manufacturers.
Patent CN114516866B details a cost-effective Evans auxiliary route for Upadacitinib intermediates, ensuring high purity and supply chain safety.
Novel patent CN114478407B enables solid-state purification of chiral homopiperazine. Reduces costs and enhances supply chain reliability for pharmaceutical manufacturing.
Patent CN116102464B details asymmetric hydrogenation for high-purity chiral amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110551033B details a novel Ir-catalyzed asymmetric reductive amination method. Achieve high enantioselectivity and cost reduction in chiral amine manufacturing with scalable processes.
Patent CN110551033B details a high-efficiency iridium-catalyzed asymmetric reductive amination method. Achieve superior enantioselectivity and cost reduction in chiral amine manufacturing for pharma and agrochemicals.
Patent CN110551032A details iridium catalyzed asymmetric reductive amination. Delivers high purity chiral amines with significant supply chain and cost advantages.
Patent CN110194735B details a visible light catalytic method for chiral amines. Offers high ee values and metal-free conditions for efficient API intermediate manufacturing.
Novel ester-based route for (3S,4S)-2,5-dioxytetrahydrofuran-3,4-bis-benzyl carbamate eliminates Pd/C, reducing costs and improving scalability for chiral catalyst manufacturing.
Patent CN110903189B details a cost-effective copper-catalyzed route for chiral 2-aryl propionates, offering significant supply chain advantages for NSAID intermediate manufacturing.
Patent CN110551036A reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and supply chain reliability for agrochemical intermediates.
Patent CN102030690B details a novel two-step synthesis of axially chiral bissulfoxide ligands, offering high enantioselectivity and streamlined manufacturing for asymmetric catalysis applications.